Abstract:Toll-like receptors (TLRs) belong to the Toll–interleukin 1 receptor superfamily, which is defined by a common intracellular Toll-IL-1 receptor (TIR) domain. A group of TIR domain containing adaptors (MyD88, TIRAP, TRIF and TRAM), are differentially recruited to the Toll-IL-1 receptors, contributing to the specificity of signaling. The IL-1 mediated signaling pathway serves as a “prototype” for other family members. Genetic and biochemical studies reveal that IL-1R uses adaptor molecule MyD88 to mediate a very complex pathway, involving a cascade of kinases organized by multiple adapter molecules into signaling complexes, leading to activation of the transcription factor NFκB. Several Toll-like receptors utilize variations of the “prototype” pathway by employing different adaptor molecules. Double-stranded RNA triggered, TLR3-mediated signaling is independent of MyD88, IRAK4, and IRAK. The adapter molecule TRIF is utilized by TLR3 to mediate the activation of NFκB and IRF3. LPS-induced, TLR4-mediated signaling employs multiple TIR-domain containing adaptors, MyD88/TIRAP to mediate NFκB activation, TRIF/TRAM for IRF3 activation. Recent studies have also begun to unravel how these pathways are negatively regulated. SIGIRR (also known as TIR8), a member of TIR superfamily that does not activate the transcription factors NFκB and IRF3, instead negatively modulates responses. Cells from SIGIRR-null mice show enhanced activation in response to either IL-1 or certain Toll ligands. In addition to SIGIRR, several other negative regulators have been shown to inhibit the TIR signaling, including ST2, IRAKM, MyD88s, SOCS1, and Triad3A. The coordinated positive and negative regulation of the TIR signaling ensures the appropriate modulation of the innate and inflammatory responses

The Essential Role Of Single Ig Il-1 Molecule/Toll Il-1r8 In Regulation Immune Response

The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.

Il-33, an Interleukin-1-Like Cytokine That Signals Via the Il-1 Receptor-Related Protein St2 and Induces T Helper Type 2-Associated Cytokines

SIGIRR, a Negative Regulator of Toll-like Receptor–interleukin 1 Receptor Signaling

SIGIRR / TIR8: A Negative Regulator of Toll-IL-1R Signaling

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

Modulation of Toll–interleukin 1 receptor mediated signaling

SIGIRR Inhibits Interleukin-1 Receptor- and Toll-Like Receptor 4-Mediated Signaling Through Different Mechanisms.

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

Suppression of Tumorigenicity 2 (st2) Signaling is Required for Regulatory T Cell Control of Graft-Vs. Host Disease

IL-33-induced Alterations in Murine Intestinal Function and Cytokine Responses Are MyD88, STAT6, and IL-13 Dependent.

The Toll–Interleukin-1 Receptor Member SIGIRR Regulates Colonic Epithelial Homeostasis, Inflammation, and Tumorigenesis

Signaling and Functions of Interleukin-33 in Immune Regulation and Diseases

Research Progress on the Negative Regulatory Function of SIGIRR to IL-1R/TLRs Signal Pathway

Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung

Il-33 Synergizes With Tcr And Il-12 Signaling To Promote The Effector Function Of Cd8(+) T Cells

IL-33 Promotes Type 1 Cell-Mediated Immunity and Has a Potent Antitumor Function (46.25)

ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses

Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity.